Dr. Thomas Danne to Receive Children with Diabetes Award at Conference

Dr. Thomas Danne Honored with CWD President's Award for Innovation

On March 13, Dr. Thomas Danne, the Chief Medical Officer of Breakthrough T1D, will receive the prestigious Children with Diabetes (CWD) President's Award for Innovation. This accolade is a tribute to his significant leadership role in enhancing diabetes healthcare through advanced technology and innovative solutions.

Recognition at a Major Conference
The award will be presented during the Advanced Technologies & Treatment for Diabetes conference held in Barcelona, Spain. Dr. Danne's commitment to improving the lives of those with type 1 diabetes (T1D) has made a notable impact in the healthcare community, and this recognition marks an important milestone in his career.

Pioneering Work in Diabetes Care
Dr. Danne is highly regarded for his extensive background in endocrinology and pediatric diabetes. Over the years, he has spearheaded numerous research initiatives aimed at enhancing clinical practices globally. As the CMO of Breakthrough T1D, he leads the Medical Affairs strategy with an aim to bridge the gap between access and the adoption of life-changing therapies for individuals living with T1D.

Previously, he served as the Director of General Pediatrics, Endocrinology, and Clinical Research at the Auf der Bult Hospital for Children and Adolescents, which is Germany's largest pediatric diabetes center. His educational journey began at the Free University Berlin Children's Hospital, followed by an accomplished career that included a fellowship at the Joslin Diabetes Center at Harvard Medical School.

Leadership Beyond Borders
Dr. Danne's contributions extend beyond his role at Breakthrough T1D. He has served as both the Secretary-General and President of the International Society for Pediatric and Adolescent Diabetes, and he was deeply involved in the SWEET Registry, impacting pediatric diabetes quality care on a global scale. His leadership in these roles demonstrates his unwavering commitment to ensuring the best possible outcomes for children and adolescents dealing with diabetes.

Supporting T1D Community through Innovation
As the leading global organization for type 1 diabetes research and advocacy, Breakthrough T1D stands at the forefront of facilitating advancements in medical research and therapy development. Founded to improve everyday life for those with T1D, Breakthrough T1D also prioritizes advocacy efforts with various government bodies to drive favorable policies and practices that support the T1D community.

Understanding Type 1 Diabetes
Type 1 diabetes is an autoimmune condition that results in little to no insulin production by the pancreas, creating significant reliance on insulin therapy and increasing the risk of both short and long-term complications. Currently, it affects approximately 9.5 million people globally. It is important to note that T1D can manifest in childhood or adulthood, and is unrelated to dietary or lifestyle choices. While researchers continue to explore the causes of this complex disease, both genetic factors and environmental triggers are believed to be involved.

With no cure currently available for T1D, the advancement of innovative therapies and improved care practices remains paramount. Dr. Danne's work symbolizes the hope and progress that is possible through dedicated research and advocacy, making a lasting impression in the lives of many.

More details about the award and Dr. Danne are available at the Children with Diabetes website.